CMOTEC-BScandinavian ChemoTech AB (publ)

STO · SE · Healthcare · Biotechnology · chemotech.se

3.090SEK+1.31%Mkt Cap: 9.20M $P/E: —4d ago

Neem's Hill AB, a medical technology company, engages in the development of patented treatment alternatives for humans and animals with cancer in Sweden and internationally. It offers IQwave, an electroporation that gene…

Key Statistics

Company

Market Cap9.20M $

Enterprise Value8.75M $

Revenue (TTM)1.21M $

Gross Profit984.83K $

Net Income (TTM)-770.57K $

Revenue/Share0.0492 USD

Last Price3.090 SEK

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees1

CountrySE

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-17.95

EV/Revenue7.25

P/S7.63

P/B57.34

EPS (TTM)-0.24

EPS (Forward)—

52W Range

2.7008% of range7.760

52W High7.760 SEK

52W Low2.700 SEK

Profitability

Gross Margin83.81%

Oper. Margin-49.29%

EBITDA Margin-40.39%

Profit Margin-65.58%

ROE-252.86%

ROA-61.03%

Growth

Revenue Growth13.20%

Earnings Growth—

Cash Flow & Leverage

Operating CF-358.22K $

CapEx (TTM)41.80K $

FCF Margin-12.69%

FCF Yield-1.66%

Net Debt-139.17K $

Net Debt/EBITDA0.29

Balance Sheet

Debt/Equity0.00

Current Ratio0.79

Quick Ratio0.46

Book Value/Sh0.0640 SEK

Cash/Share0.0570 SEK

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 SEK

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)6.300 SEK

Upside (mean)+103.9%

Target Range6.300 SEK – 6.300 SEK

# Analysts1

Ownership

Shares Out.23.80M

Float13.07M

Insiders42.26%

Institutions3.37%

Technical

SMA 503.622 (-14.7%)

SMA 2003.983 (-22.4%)

Beta0.96

S&P 52W Chg18.16%

Avg Vol (30d)11.70K

Avg Vol (10d)11.24K

Technical Indicators

RSI (14)40.0

MACD-0.1116

MACD Signal-0.0954

MACD Hist.-0.0162

BB Upper3.581 SEK

BB Middle3.269 SEK

BB Lower2.957 SEK

BB Width19.08%

ATR (14)0.2489 SEK

Vol Ratio (20d)1.44x

CMOTEC-BScandinavian ChemoTech AB (publ)

Industry Peers

Key Statistics